Skip to Main Content

mental health

Here you’ll find the latest in mental health research related to postpartum depression and major depressive disorder, schizophrenia, bipolar disorder and more. Stories here tackle issues related to psychologists, psychiatrists — and patients.

Recent articles include the mainstreaming of hallucinogenic drugs in mental health therapy, a study of autism and self-harm, a look at a schizophrenia gene, and possible links between mental illness and drug addiction.

Latest

In the Lab Annalisa Merelli

Esketamine tops quetiapine for treatment-resistant depression in head-to-head trial

Health Annalisa Merelli

Nurses and health care support workers at higher risk of suicide, study finds

First Opinion Amelia Mercado and J. Wesley Boyd

How medical schools are failing students who need mental health care

First Opinion Mark Goldstein

Every smartphone should have an app to connect to 988, the mental health crisis line

First Opinion Kristina Bohdanova, Marina Weiss and Samantha Weckesser

Lessons from Ukraine on protecting mental health during conflict

Health Tech Mohana Ravindranath

STAT Plus: Researchers use AI to measure recovery from treatment-resistant depression

Politics Sarah Owermohle

STAT Plus: Rep. Adam Smith weighs in on the country’s mental health crisis with his own story

Health Annalisa Merelli

STAT Plus: New study adds to evidence on psychedelic as effective treatment for PTSD

All Coverage

Health Grace Rubenstein

They’re immigrants, farmworkers, and new moms. And they’re facing postpartum depression at higher rates

Health Annalisa Merelli

STAT Plus: One dose of psilocybin may have lasting effects on major depression, study finds

advertisement

Health Isabella Cueto

Emotional dry cleaning: A writer helps doctors share their stories — and their pain

First Opinion Sharmila B. Mehta

How learning the truth about chaos theory has helped me as an inpatient child psychologist

First Opinion Simone Bernstein and Jessica Gold

STAT Plus: Psychiatrists like us cannot keep up with their inboxes

Biotech Allison DeAngelis

STAT Plus: Neuroscience startup Neumora files for IPO

First Opinion Morgan S. Levy, Vineet Arora and Arghavan Salles

Medicine robs physicians of their fertility. Here’s how to fix it

In the Lab Isabella Cueto

STAT Plus: Schizophrenia gene found to be linked to energy dysfunction in brain cells

Health Annalisa Merelli

Study shows autistic people are more likely to engage in self-harm — but not because of autism

Health Annalisa Merelli

Half of people worldwide at risk of developing mental health condition by age 75, per new study

Biotech Brittany Trang

STAT Plus: Sage considers ways to reduce costs following FDA rejection on drug for major depression

Biotech Brittany Trang

STAT Plus: FDA approves Sage Therapeutics’ rapid-acting medication for postpartum depression but not major depression

Health Tech Lizzy Lawrence

STAT Plus: Flow Neuroscience shows promising results in trial of brain-stimulation headset for depression

Biotech Brittany Trang

STAT Plus: Sage hopes for a blockbuster in fast-acting antidepressant now before FDA

Health Tech Mario Aguilar

STAT Plus: With profitability in sight, Talkspace is budding into a digital health success story

Politics Simar Bajaj

STAT Plus: Mental illness, drug addiction go hand in glove, Biden’s drug czar tells lawmakers

Hospitals Tara Bannow

STAT Plus: UHS finance chief said company favors patients whose insurance pays more

Health Lev Facher

White House unveils plan to make insurers cover mental health care

Exclusive Mario Aguilar

STAT Plus: App developer Twill hunts for pharma partner to market its digital depression treatment

First Opinion Podcast Torie Bosch

Listen: Dance helped this nurse heal from trauma. Now she’s bringing it to others

Biotech Damian Garde

STAT Plus: Startup Neumora takes a novel depression drug to Phase 3